Amphastar Pharmaceuticals (AMPH) Tax Provisions (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Tax Provisions of $3.6 million for Q1 2026, down 34.88% year-over-year from $5.6 million in Q1 2025, and up 123.18% quarter-over-quarter from -$15.7 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Tax Provisions (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Tax Provisions history runs 14 years deep, the most recent figure standing at $3.6 million for Q1 2026.
- In Q1 2026, Tax Provisions fell 34.88% year-over-year to $3.6 million; the TTM figure through Mar 2026 stood at $431000.0 (down 98.62% YoY), while the FY2025 annual figure was $2.4 million, down 91.99% from the prior year.
- Tax Provisions for Q1 2026 stood at $3.6 million, up from -$15.7 million in the prior quarter.
- The five-year high for Tax Provisions was $14.0 million in Q3 2023, with the low at -$15.7 million in Q4 2025.
- The 5-year median for Tax Provisions is $6.0 million (2024), against an average of $5.4 million.
- The sharpest annual moves came in 2022 and 2025: Tax Provisions jumped 252.99% in 2022, then sank 361.24% in 2025.
- Amphastar Pharmaceuticals' Tax Provisions stood at $7.3 million in 2022, then plunged by 35.9% to $4.7 million in 2023, then climbed by 28.35% to $6.0 million in 2024, then tumbled by 361.24% to -$15.7 million in 2025, then surged by 123.18% to $3.6 million in 2026.
- Business Quant data shows AMPH's Tax Provisions at $3.6 million in Q1 2026, -$15.7 million in Q4 2025, and $4.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 931.14 Mn | 641.02 Mn | 93.47 Mn | 8.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.20 Mn |
| Mar 31, 2026 | 3.63 Mn |
| Dec 31, 2025 | -15.67 Mn |
| Sep 30, 2025 | 4.16 Mn |
| Jun 30, 2025 | 8.31 Mn |
| Mar 31, 2025 | 5.58 Mn |
| Dec 31, 2024 | 6.00 Mn |
| Sep 30, 2024 | 7.25 Mn |
| Jun 30, 2024 | 12.29 Mn |
| Mar 31, 2024 | 4.13 Mn |
| Dec 31, 2023 | 4.67 Mn |
| Sep 30, 2023 | 14.03 Mn |
| Jun 30, 2023 | 6.38 Mn |
| Mar 31, 2023 | 6.75 Mn |
| Dec 31, 2022 | 7.29 Mn |
| Sep 30, 2022 | 6.56 Mn |
| Jun 30, 2022 | 5.55 Mn |
| Mar 31, 2022 | 4.08 Mn |
| Dec 31, 2021 | 7.19 Mn |
| Sep 30, 2021 | 6.69 Mn |